Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial

Keyphrases

• Maintenance Therapy 100%
• Multicenter Randomized Controlled Trial 100%
• Ulcerative Colitis 100%
• Apheresis 100%
• Clinical Remission 36%
• Endoscopic Remission 36%
• Remission 18%
• Remission Rate 18%
• Granulocytes 9%
• Leukocytes 9%
• Randomized Controlled Trial 9%
• Prospective Randomized Trial 9%
• Adsorption 9%
• Monocytes 9%
• Selective Removal 9%
• Severe Adverse Events 9%
• Ulcerative Colitis Patient 9%
• Allocation Ratio 9%
• March 2013 9%
• Leukocytapheresis 9%

Medicine and Dentistry

• Maintenance Therapy 100%
• Randomized Controlled Trial 100%
• Patient with Ulcerative Colitis 100%
• Apheresis 100%
• Ulcerative Colitis 36%
• Spontaneous Remission 18%
• Adverse Event 9%
• Granulocyte 9%
• Leukocyte 9%
• Leukapheresis 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Remission 100%
• Ulcerative Colitis 100%
• Adverse Event 9%